Navigation Links
Phase 2b Trial Shows Unique Lipid Efficacy Profile of Novel Compound to Reduce Elevated Triglyceride Levels
Date:2/29/2012

SAN DIEGO, Feb. 29, 2012 /PRNewswire/ -- Essentialis, Inc., today announced Phase 2b trial results for its investigational compound DCCR demonstrating a reduction in triglyceride (TG) levels by 30 to 40 percent in patients whose TG levels exceeded 500 mg/dL (Very High Triglycerides [VHTG]). The study included an arm combining DCCR with fenofibrate treatment (Abbott Laboratories' Trilipix® (fenofibric acid)); in the combination arm, DCCR was shown to be additive to fenofibrate for all lipid fractions except LDL-C. In contrast, a 2009 study of VHTG patients using prescription omega-3 fatty acid in combination with fenofibrate revealed no clinically important change compared to fenofibrate alone(1).

More than five million people in the United States have very high TG levels. This population is at elevated risk for a number of diseases, including acute pancreatitis, diabetes and cardiovascular events (e.g., sudden death, myocardial infarction, acute coronary syndrome, revascularization, stroke and atrial fibrillation).

"The results of this study contribute to the growing body of knowledge on the potential of DCCR as a triglyceride-lowering treatment," said Richard C. Pasternak, M.D., Essentialis board member and head of the Company's scientific advisory board. "These data clearly motivate us to advance DCCR into larger trials that may demonstrate benefit to patients with multiple disease risk factors."

In this Phase 2b double-blind, placebo-controlled study, subjects were included in one of two sub-groups. About half of the subjects were included in the atorvastatin combination sub-group, where they were randomized to receive either DCCR 290 mg or placebo in combination with atorvastatin (Pfizer Inc.'s Lipitor®) 20 mg for 18 weeks. The remaining subjects in the study were included in the monotherapy/fenofibrate combination subgroup, where they were randomized to receive either DCCR 290 mg or placebo for 12 weeks, followed by co-adm
'/>"/>

SOURCE Essentialis, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. Thomson Scientific Publishes The Ones to Watch - A Quarterly Review of Phase Changes in the Pharmaceutical Pipeline
3. Progen Engages Leading CRO to Assist with Phase 3 Trial of PI-88
4. The Multiple Myeloma Research Consortium (MMRC) and Proteolix Initiate Phase 2 Clinical Trial Investigating Carfilzomib for the Treatment of Multiple Myeloma
5. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
6. Multiple Myeloma Research Consortium (MMRC) Partners with Novartis to Advance Phase II Study of Deacetylase Inhibitor
7. Positive Kuvan(TM) Pivotal Phase 3 Trial Results Published in The Lancet
8. Potential Safety Issue Identified in Ongoing Phase 2 Clinical Study of HCV-796
9. TaiGen Biotechnology Successfully Completes Patient Recruitment for Phase II Trial of Nemonoxacin for Treatment of Adult Community Acquired Pneumonia (CAP)
10. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
11. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2014)... 21, 2014 Clementia Pharmaceuticals, ... Agency (EMA) has granted Orphan Medicinal Product ... candidate, for the treatment of fibrodysplasia ossificans ... disabling genetic disease characterized by painful, recurrent ... new abnormal bone formation. This process, known ...
(Date:11/21/2014)... , Nov. 20, 2014 /PRNewswire/-- CANTEL MEDICAL CORP. (NYSE: ... , Chief Executive Officer, will be presenting at the 26 ... York Palace Hotel in New York . ... at 2:00 PM ET. In addition, Mr. Krakauer and ... for separate one-on-one meetings during the day. ...
(Date:11/21/2014)... , 21. November 2014 Michael ... sich am Morgen des 14. Februar 2014 zugetragen hat. ... wohl kaum vergessen. Video - http://youtu.be/5cVoMCe0uiE ... ich dabei war, mein morgendliches Training zu machen", erzählt ... zu der Zeit begeisterte Anhänger der CrossFit-Trainingsmethode. ...
Breaking Medicine Technology:Clementia Pharmaceuticals Receives EMA Orphan Medicinal Product Designation for Palovarotene for the Treatment of Fibrodysplasia Ossificans Progressiva 2Clementia Pharmaceuticals Receives EMA Orphan Medicinal Product Designation for Palovarotene for the Treatment of Fibrodysplasia Ossificans Progressiva 3Tochter rettet Vater durch Herz-Lungen-Wiederbelebung vor plötzlichem Herztod 2Tochter rettet Vater durch Herz-Lungen-Wiederbelebung vor plötzlichem Herztod 3
(Date:11/21/2014)... 21, 2014 TruDenta, the creator of ... and other jaw-related symptoms, has reported a nationwide ... chronic head pain, neck pain, TMJ (temporomandibular joint) disorder, ... we have seen a 52% increase in the number ... over 300 doctors and their teams in 47 states ...
(Date:11/21/2014)... DressVe.com , a renowned women’s dress wholesaler and retailer ... fashion accessories. Furthermore, the company has launched its Special Black ... all its fashion items. Also, orders above $59 are qualified ... company, their wedding dresses and prom dresses are very popular ... rates. , The CEO says “We are glad to ...
(Date:11/21/2014)... (PRWEB) November 21, 2014 Recently, TideStore.com, ... fashion accessories, has announced its special offer TideStore ... the items at TideStore.com are now provided with big ... – 25. People can enjoy an extra 10% discount ... submit their email addresses and have opportunities to win ...
(Date:11/21/2014)... City, MO (PRWEB) November 21, 2014 ... to Melancholy Lift, an industry leader in the ... of people have significant feelings of sadness and ... help from traditional pharmaceutical choices. Often, prescription drugs ... of depression. Prescription drugs are expensive and require ...
(Date:11/21/2014)... (PRWEB) November 21, 2014 RankingBySEO has ... manage the online reputation of lawyers, and the company ... has announced the service for lawyers since it receives ... online reputation in big numbers. So far, the company ... and law firms in different parts of the world, ...
Breaking Medicine News(10 mins):Health News:National Rise In Patients Seeking Headache Relief 2Health News:DressVe.com Announces Its 2014 Special Friday Sales 2Health News:Thanksgiving Sales from TideStore.com 2Health News:Depression Relief Product Receives Top 5-Star Rating from TopConsumerReviews.com 2Health News:RankingBySEO Announces Lawyer Reputation Management Service 2
... PORTLAND, Ore., Sept. 9 The following is a statement from Mark ... , "These are extraordinary times. Our nation is in ... applaud our nation,s leaders for making this difficult issue a priority. , ... our country. Some of the rhetoric turned quite ugly. The ...
... , TAMPA, Fla., Sept. 9 Calling all walkers, joggers, bikers and avid health & exercise buffs. Calling all couch potatoes, procrastinators, ... , ... Thursday, September ... University Mall, ...
... , WYNNEWOOD, Pa., Sept. 9 CureDM, Inc., ... Diabetes Mellitus, announced today that CureDM has been chosen as ... 2009 for its development of Pancreate(TM), a human peptide therapeutic. ... Healthcare Product Innovation of the Year Award is bestowed upon ...
... Sept. 9 After an extensive national search, Robert Croner has ... Hospital of Philadelphia. , , Croner has ... at the executive level for the past 20 years. Prior ... of Human Resources. , , "The knowledge ...
... , COLUMBIA, Md., Sept. 9 ... and Hard of Hearing Community, Purple Communications(TM), Inc. (Nasdaq: ... Bienvenu, linguistics doctorate and Professor of American Sign Language (ASL) ... Community members are encouraged to join in the celebration ...
... WASHINGTON, Sept. 9 The United We Serve program helped ... a notable increase in young volunteers, in particular, since the launch ... (Logo: http://www.newscom.com/cgi-bin/prnh/20090108/RedCrossLOGO ) , , ... on Friday, September 11, with a National Day of Service and ...
Cached Medicine News:Health News:Health Insurer Regence Continues to Advocate for Meaningful Health Reform 2Health News:Grand Opening: An Exercise Program for People Who Just Love To Dance 2Health News:CureDM Awarded 2009 Diabetes Product Innovation of the Year by Frost and Sullivan 2Health News:CureDM Awarded 2009 Diabetes Product Innovation of the Year by Frost and Sullivan 3Health News:The Children's Hospital of Philadelphia Names New Senior Vice President of Human Resources 2Health News:Purple Communications Invites Greater Baltimore Area Community To Celebrate Dr. MJ Bienvenu, Finalist in 'Dream Bigger' Initiative 2Health News:Purple Communications Invites Greater Baltimore Area Community To Celebrate Dr. MJ Bienvenu, Finalist in 'Dream Bigger' Initiative 3Health News:Purple Communications Invites Greater Baltimore Area Community To Celebrate Dr. MJ Bienvenu, Finalist in 'Dream Bigger' Initiative 4Health News:Purple Communications Invites Greater Baltimore Area Community To Celebrate Dr. MJ Bienvenu, Finalist in 'Dream Bigger' Initiative 5Health News:Red Cross Sees Increase in Youth Volunteers During United We Serve Program 2Health News:Red Cross Sees Increase in Youth Volunteers During United We Serve Program 3
... This program module functions stand alone. It ... the ophthalmicsuite product. The ASC module is ... in ophthalmic surgical specialty. Cataract, cosmetic, strabismus, ... The ASC forms are adapted to your ...
... the perfect solution to assist you in managing ... of your practice through the creative use of ... No more impatient clients waiting to see the ... patient records. No more illegible handwriting on all ...
... produces patient care reports for cardiology ... physician reporting and documentation tool, physicians ... images, H&P, labs, medications, and procedural ... signed with an e-signature, and distributed ...
... The worlds most accurate ultrasonic technology. ... refractive surgery you will want to use ... comes from a combination of analog and ... different way than all the other ultrasonic ...
Medicine Products: